Level Bio AB (FRA:4MB) EPS without NRI: €-0.00 (TTM As of Mar. 2026)


FRA:4MB Level Bio AB FRA:4MB
23 GF Score
Price €0.01
! 4 Warning Signs
View Full Analysis

What is Level Bio AB EPS without NRI?

Level Bio AB FRA:4MB +8.00% 23 EPS without NRI is €-0.00 as of Mar. 2026. GuruFocus rates FRA:4MB with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 160 Medical Diagnostics & Research companies, Level Bio AB ranks worse than 75% on this metric.

Level Bio AB's earnings per share without non-recurring items for the three months ended in Mar. 2026 was €0.00. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.00.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Level Bio AB's EPS without NRI or its related term are showing as below:

FRA:4MB' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -65.1   Med: 22.45   Max: 89
Current: -6.8

During the past 13 years, Level Bio AB's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 89.00% per year. The lowest was -65.10% per year. And the median was 22.45% per year.

FRA:4MB's 3-Year EPS without NRI Growth Rate is ranked worse than
75% of 160 companies
in the Medical Diagnostics & Research industry
Industry Median: 10.95 vs FRA:4MB: -6.80

Level Bio AB's EPS (Diluted) for the three months ended in Mar. 2026 was €0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.00.

Level Bio AB's EPS (Basic) for the three months ended in Mar. 2026 was €0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was €-0.00.


Level Bio AB  (FRA:4MB) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Level Bio AB EPS without NRI Related Terms


Level Bio AB EPS without NRI Historical Data

* Premium members only.

The historical data trend for Level Bio AB's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Bio AB EPS without NRI Chart

Level Bio AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 -0.00 -0.01 -0.01 -0.01

Level Bio AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 0.00 -0.00 0.00

FRA:4MB vs TMO, DHR, IDXX: EPS without NRI Comparison

For the Diagnostics & Research subindustry, Level Bio AB's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Bio AB PE Ratio without NRI vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Level Bio AB's PE Ratio without NRI falls into.


FRA:4MB
23GF Score
Level Bio AB FRA:4MB
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Level Bio AB EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €-0.00 mean?
Level Bio AB (FRA:4MB) has a EPS without NRI of €-0.00 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Level Bio AB and its competitors. According to the industry distribution chart, Level Bio AB ranks #120 out of 160 companies in the Medical Diagnostics & Research industry, placing it in the top 75%.
Is Level Bio AB's EPS without NRI too high?
Level Bio AB's current EPS without NRI is €-0.00. Based on the distribution chart, Level Bio AB ranks #120 out of 160 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Level Bio AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Level Bio AB's EPS without NRI compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Level Bio AB ranks #120 out of 160 companies for EPS without NRI. This places Level Bio AB in the lower half of its industry. The industry median EPS without NRI is 10.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Diagnostics & Research company?
The median EPS without NRI among Medical Diagnostics & Research companies is 10.95, based on 160 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Level Bio AB and its competitors. For the Medical Diagnostics & Research industry, the median EPS without NRI is 10.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Level Bio AB's current EPS without NRI is €-0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Level Bio AB stock overvalued right now?
Level Bio AB (FRA:4MB) has a current EPS without NRI of €-0.00. The current EPS without NRI is €-0.00. Level Bio AB's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Level Bio AB (FRA:4MB), the current EPS without NRI is €-0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Level Bio AB Business Description

Other Exchanges LEVBIO:Sweden
Address Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
Level Bio AB is a parent company and operates through subsidiary. It develops and manufactures diagnostic kits for the clinical market and also is a distributor and full service partner to molecular biology labs in the Nordics.
23GF Score

Get the complete analysis for FRA:4MB

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price